MONTEVIDEO, Uruguay, March 19, 2018 /PRNewswire/ -- Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q17 and full year of 2017.
HIGHLIGHTS
Gross revenues for 4Q17 grew 14% in constant currency, totaling BRL 271.6M.
Net revenues for 4Q17 increased by 17.8% in constant currency, totaling BRL 244.4M.
Gross profit up 14.4% in 4Q17, in constant currency, totaling BRL 140.3M. Gross margin of 57.4%.
Adjusted EBITDA grew 5.5% in constant currency vs. 4Q16, amounting to BRL 73.2M in 4Q17. 19.2% growth excluding from the base an insurance recovery decoupled from its underlying loss (in 2Q17)
Adjusted net income up 6.9% in nominal terms from 4Q16, reaching BRL 36.9M in 4Q17.
Net revenues for full year 2017 at 817.5M, with 14% organic growth (excluding exchange rate effects, short-term businesses, divestitures and acquisitions).
Adjusted EBITDA reached BRL 199.4M in 2017, up 23.9% in constant currency.
Gross margin for full year 2017 improved 3.8 pp when compared to 2016, reaching 53.8%. Adjusted EBITDA margin improved 2.5 pp, reaching 24.4%, in the same period.
Tri Ri Asset Management ("TRAM") is pleased to announce a strategic investment from its flagship venture capital fund, the TRAM Venture Fund ("TRAM VF"), in OUNO, a pioneering executive ride-hailing platform headquartered in London. This...
Just in time for its fourth anniversary, MARKT-PILOT announces the successful completion of one of Europe's largest Series A financing rounds, led by global software investor Insight Partners with participation from existing investor Capnamic. The...
Encore Wire Corporation ("Encore Wire" or the "Company") today announced results for the first quarter of 2024.
First Quarter Highlights
First Quarter Earnings per diluted share of $3.92
First Quarter Net Income of $63.3 million
Gross...
Cabbacis (the "Company"), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that it has filed its Annual Report on Form 1-K for the fiscal year ended December 31, 2023...
Sturm, Ruger & Company, Inc. will announce its financial results for the first quarter 2024 and file its Quarterly Report on Form 10-Q on Tuesday, May 7, 2024, after the close of the stock market.
On Wednesday, May 8, 2024, Sturm, Ruger will host...
DXC Technology today announced that it will release financial results for the fourth quarter of fiscal year 2024 on Thursday, May 16, 2024, at approximately 4:15 p.m. Eastern Daylight Time (EDT).
DXC Technology senior management will host a...
